Crossmark

Pharmacological effects of N-[2-[[2-[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]ethyl]hyaluronamide (diclofenac Etalhyaluronate, SI-613), a novel sodium hyaluronate derivative chemically linked with diclofenac

Crossref DOI link: https://doi.org/10.1186/s12891-018-2077-8

Published Online: 2018-05-22

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yoshioka, Keiji

Kisukeda, Tomochika

Zuinen, Ryoji

Yasuda, Yosuke

Miyamoto, Kenji
License Information

Text and Data Mining valid from 2018-05-22
More Information

Article History

Received: 2 November 2017

Accepted: 7 May 2018

First Online: 22 May 2018

Ethics approval

: The animal studies were reviewed and approved by the Animal Experiment Ethics Committee of Seikagaku Corporation and performed under the animal husbandry/management system in an appropriate environment with animal protection/welfare in mind.

: All authors of this paper are employees of Seikagaku Corporation. The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below